|
⚲
|
| Keyboard |
| Peter Svennilson | |
|---|---|
| Firm | The Column Group Management LP |
| Address | c/o Ngm Bio Holdings, Inc 611 Gateway Blvd, Suite 540 South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| The Column Group Management LP | |||||
| The Column Group Opportunity IV LP | 021-567040 | Executive Officer | of 600.0 M |
270.6 M | |
| The Column Group VI LP | 021-567039 | Executive Officer | of 600.0 M |
270.6 M | |
| The Column Group - Neuro II LP | 021-505164 | Executive Officer | 100.0 M of 100.0 M |
98.5 M | |
| The Column Group Opportunity III LP | 021-449435 | Executive Officer | 600.0 M of 600.0 M |
489.2 M | |
| The Column Group SPV I LP | 021-466953 | Executive Officer | 10.5 M of 10.5 M |
10.3 M | |
| The Column Group V LP | 021-449432 | Executive Officer | 600.0 M of 600.0 M |
533.5 M | |
| The Column Group - Neuro LP | 021-399536 | Executive Officer | 100.0 M of 100.0 M |
93.1 M | |
| The Column Group IVA LP | 021-355337 | Executive Officer | of 25.0 M |
22.3 M | |
| The Column Group IV LP | 021-355333 | Executive Officer | of 700.0 M |
730.1 M | |
| Ponoi Capital II LP | 021-307049 | Executive Officer | of 100.0 M |
81.6 M | |
| Ponoi Capital LP | 021-288186 | Executive Officer | of 150.0 M |
100.8 M | |
| The Column Group IIIA LP | 021-258238 | Executive Officer | 270.5 M of 270.5 M |
139.7 M | |
| The Column Group III LP | 021-258236 | Executive Officer | 239.5 M of 239.5 M |
123.6 M | |
| The Column Group II LP | 021-139445 | Executive Officer | 65.5 M of 350.0 M |
205.7 M | |
| Neurona Therapeutics Inc | 021-543006 | Director | 101.7 M of 101.7 M |
||
| NGM Bio Holdings Inc | 021-519045 | Director | 142.0 M of 142.0 M |
||
| Carmot Therapeutics Inc | 021-483450 | Director | 150.0 M of 150.0 M |
||
| Carmot Therapeutics Inc | 021-455238 | Director | 160.7 M of 160.7 M |
||
| Circle Pharma Inc | 021-404569 | Director | 66.3 M of 66.3 M |
||
| Carmot Therapeutics Inc | 021-376820 | Director | 26.3 M of 46.9 M |
||
| Circle Pharma Inc | 021-363443 | Director | 15.0 M of 45.0 M |
||
| Constellation Pharmaceuticals Inc | 021-309534 | Director | 99.0 M of 100.0 M |
||
| Constellation Pharmaceuticals Inc | 021-271333 | Director | 24.3 M of 24.3 M |
||
| NGM Biopharmaceuticals Inc | 021-236650 | Director | 106.0 M of 106.0 M |
||
| NGM Biopharmaceuticals Inc | 021-234589 | Director | 20.7 M of 60.0 M |
||
| Immune Design Corp | 021-219014 | Director | 0.0 M of 0.0 M |
||
| Immune Design Corp | 021-218940 | Director | 0.0 M of 0.0 M |
||
| Column Group II LP | 021-215382 | Executive Officer | 306.0 M of 306.0 M |
||
| Immune Design Corp | 021-205531 | Director | 48.5 M of 57.8 M |
||
| NGM Biopharmaceuticals Inc | 021-195932 | Director | 13.5 M of 50.0 M |
||
| PTC Therapeutics Inc | 021-191684 | Director | 2.0 M of 16.1 M |
||
| Aragon Pharmaceuticals Inc | 021-184610 | Director | 50.0 M of 50.0 M |
||
| PTC Therapeutics Inc | 021-179680 | Director | 23.0 M of 40.0 M |
||
| Aragon Pharmaceuticals Inc | 021-174482 | Director | 37.8 M of 42.2 M |
||
| Aragon Pharmaceuticals Inc | 021-141104 | Director | 12.0 M of 22.0 M |
||
| NGM Biopharmaceuticals Inc | 021-114428 | Director | 55.4 M of 55.7 M |
||
| Immune Design Corp | 021-119253 | Director | 0.0 M of 0.0 M |
||
| Farallon Biosciences Inc | 021-131501 | Director | 4.0 M of 8.0 M |
||
| Related People Network |
|---|
| Network #239 at PTC Therapeutics Inc — files alongside 13 co-filers |